Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis

Background: The possibility of developing a severe coronavirus infectious (COVID-19) disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has increased, particularly in patients with hematological malignancies. These patients are more likely to produce less antibody protect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JMA Journal 2024/04/15, Vol.7(2), pp.153-171
Hauptverfasser:	Barshan, Anindita Das, Matsumoto-Takahashi, Emilie Louise Akiko
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 vaccines Hematological malignancy Immunogenicity Review Seroconversion Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!